67 results
6-K
EX-99.1
GMAB
Genmab
21 May 24
Genmab Completes Acquisition of ProfoundBio
11:38am
Genmab with access to ProfoundBio’s novel ADC technology platforms, which complement Genmab’s already validated suite of proprietary technology platforms
6-K
EX-99.1
GMAB
Genmab
2 May 24
Genmab Announces Financial Results for the First Quarter of 2024
11:08am
or 12:00 pm EDT. To join the call please use the below registration link. Registered participants will receive an email with a link to access dial … %, was primarily driven by increased demand and strong access. Royalty revenue on net sales of Kesimpta was DKK 437 million in the first three months
6-K
EX-99.1
GMAB
Genmab
3 Apr 24
Genmab to Broaden and Strengthen Oncology Portfolio with Acquisition of ProfoundBio
6:19am
/BI9da0549848d848cdaa4b6cd96079bafd. Registered participants will receive an email with a link to access dial-in information as well as a unique personal PIN. To listen
6-K
EX-99.1
GMAB
Genmab
14 Feb 24
Genmab 2023 Annual Report
12:30pm
therapies, we were focused specifically on medicines for cancer. However, our knowledge of specific immunological pathways and access to unique next … , doxorubicin hydrochloride, vincristine and prednisone (R-CHOP) in adult patients with newly diagnosed DLBCL. February: Expanded Access Program launched
6-K
EX-99.1
qi08o8k1 j0alw2
14 Feb 24
Genmab 2023 Annual Report
12:30pm
6-K
EX-99.1
huh1ut3uqdrt7qe0d1
7 Nov 23
Genmab Announces Financial Results for the First Nine Months of 2023
11:12am
6-K
EX-99.1
ervfp4r2
25 Sep 23
Current report (foreign)
8:53am
6-K
EX-99.1
vd3pcb7m6 d3y4
3 Aug 23
Genmab Announces Financial Results for the First Half of 2023
11:16am
6-K
EX-99.1
t2dowim
19 May 23
Current report (foreign)
12:48pm
6-K
EX-99.1
nzcaofhn 8fztpc6k57z
10 May 23
Genmab Announces Financial Results for the First Quarter of 2023
11:23am
6-K
EX-99.1
f0iwi1 ka7six76qw7e2
9 Nov 22
Genmab Announces Financial Results for the First Nine Months of 2022
11:31am
6-K
EX-99.1
zk9havd2
10 Aug 22
Genmab Announces Financial Results for the First Half of 2022
11:25am
6-K
EX-99.1
n8avqee
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
2ntzyc7qe7rbwkktyjzd
16 Feb 22
Genmab 2021 Annual Report
11:29am
6-K
EX-99.1
lsqmi b8bf4p4v5tft6
10 Nov 21
Genmab Announces Financial Results for the First Nine Months of 2021
12:01pm